Neochim AD

Neochim AD's capital structure is characterized by a strong liquidity position, with a current ratio of 8.62, indicating that the company holds significantly more current assets than current liabilities. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative approach to leverage. Additionally, the company maintains a substantial cash and equivalents balance of 40,074,000 BGN, which supports its liquidity and operational flexibility. Despite its strong liquidity, Neochim AD reported a net loss of 5,771,000 BGN and an operating loss of 5,472,000 BGN in the latest financial period. The company's return on equity (ROE) and return on assets (ROA) were -3.96% and -3.52%, respectively, indicating poor profitability and asset utilization. These metrics fall below the typical performance benchmarks for the Agricultural Chemicals industry, suggesting that the company is underperforming relative to its peers. The company's revenue is concentrated in a single business segment focused on agricultural chemicals, with no disclosed geographic diversification. This concentration increases the company's exposure to regional economic and regulatory risks, particularly in the Eastern European market where it operates. The lack of geographic diversification may limit the company's ability to mitigate risks associated with local market conditions. Looking ahead, the company's growth trajectory appears uncertain. The latest financial data does not provide clear indicators of revenue growth or improvement in profitability. The company's free cash flow was negative at -3,601,000 BGN, and capital expenditures were relatively low at -156,000 BGN, suggesting limited investment in future growth. Without significant improvements in operational performance or strategic investments, the company may struggle to achieve sustainable growth. The risk assessment for Neochim AD indicates a low level of liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its strong cash position reduces the likelihood of near-term financial distress. However, the company's poor profitability and negative returns suggest that it may face challenges in maintaining its financial health over the long term. The absence of dilution risk is supported by the fact that the number of shares outstanding has not changed between basic and diluted shares. There are no recent events or filings that indicate significant changes in the company's operations or financial condition. The company's latest financial report does not mention any material developments, such as new product launches, regulatory changes, or strategic partnerships, that could impact its future performance.